[Butazolidine in therapy of rheumatic diseases; clinical tests with 3, 5-dioxo-1, 2-diphenyl-4-n-butyl-pyrazolidine-sodium, a new pyrazol derivative].
D000700:Analgesics / Q000627:therapeutic use*; D001713:Biphenyl Compounds; D012216:Rheumatic Diseases / Q000628:therapy*; D012964:Sodium; D012982:Sodium, Dietary
D000700:Analgesics; D001713:Biphenyl Compounds; D012964:Sodium; D012982:Sodium, Dietary; C010574:biphenyl
ANALGESICS/therapeutic use; RHEUMATISM/therapy
Rheumatherapie mit Butazolidin; Klinische Erfahrungen mit 3, 5-Dioxo-1, 2-diphenyl-4-n-butyl-pyrazolidin-Natrium, einem neuen Pyrazolderivat.